|
BCL7B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.77849998564506E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.52169995995644E-09 |
| Normal-vs-Stage2 |
2.983500E-02 |
| Normal-vs-Stage3 |
1.847210E-01 |
| Normal-vs-Stage4 |
3.281000E-01 |
| Stage1-vs-Stage2 |
4.135000E-01 |
| Stage1-vs-Stage3 |
1.841880E-02 |
| Stage1-vs-Stage4 |
2.007000E-01 |
| Stage2-vs-Stage3 |
2.512000E-01 |
| Stage2-vs-Stage4 |
5.420600E-01 |
| Stage3-vs-Stage4 |
8.088800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.31780000140114E-08 |
| Normal-vs-AfricanAmerican |
8.48740000000126E-05 |
| Normal-vs-Asian |
4.398200E-01 |
| Caucasian-vs-AfricanAmerican |
7.811800E-01 |
| Caucasian-vs-Asian |
6.087200E-01 |
| AfricanAmerican-vs-Asian |
5.614200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.53409967956964E-10 |
| Normal-vs-Female |
4.076800E-03 |
| Male-vs-Female |
2.306200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.508200E-02 |
| Normal-vs-Extreme_Weight |
3.43459999996298E-07 |
| Normal-vs-Obese |
2.04149999999403E-05 |
| Normal-vs-Extreme_Obese |
5.540100E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.741700E-02 |
| Normal_Weight-vs-Obese |
4.179400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.671400E-01 |
| Extreme_Weight-vs-Obese |
2.088200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.970200E-01 |
| Obese-vs-Extreme_Obese |
6.937600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.087700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.00459999985425E-07 |
| Normal-vs-Age(61-80Yrs) |
4.87130000004221E-07 |
| Normal-vs-Age(81-100Yrs) |
3.167800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.062800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.713000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.719000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.145600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.915000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.609600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.4432899320127E-15 |
| Normal-VS-Type2 PRCC |
1.866030E-01 |
| Normal-VS-KIRP CIMP |
4.828800E-01 |
| Normal-VS-Unclassified PRCC |
6.120400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.96509999781125E-08 |
| Type1 PRCC-VS-KIRP CIMP |
2.19310000004747E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
4.447800E-04 |
| Type2 PRCC-VS-KIRP CIMP |
1.271450E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.143400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.411970E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.616150E-02 |
| Normal-vs-N1 |
7.965600E-01 |
| Normal-vs-N2 |
8.234800E-01 |
| N0-vs-N1 |
5.054400E-02 |
| N0-vs-N2 |
5.045000E-01 |
| N1-vs-N2 |
7.897400E-01 |
|
|
